Metraipolis › archive › dc_b802f4ec7dcc

Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the… — Europe PMC PMID:42160910

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42160910
DOI
10.1016/j.breast.2026.104815
License (as archived)
solo-consultazione
Archived
2026-11-01T15:36:27.164Z
SHA-256 of the archived text
d72b901b0dd697cdcec927db135d4d8b2be25f2cc3372562fbe920184988333f
Stable URL of this page
https://metraipolis.com/documento/dc_b802f4ec7dcc

How to cite

Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the… — Europe PMC PMID:42160910 — Europe PMC (en), https://europepmc.org/article/MED/42160910 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b802f4ec7dcc (Metraipolis archive dc_b802f4ec7dcc, sha256 d72b901b0dd697cdcec927db135d4d8b2be25f2cc3372562fbe920184988333f)
BibTeX
@misc{dcb802f4ec7dcc,
  title = {Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the… — Europe PMC PMID:42160910},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42160910},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b802f4ec7dcc; sha256 d72b901b0dd697cdcec927db135d4d8b2be25f2cc3372562fbe920184988333f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42160910. Agents can read the archived copy with the MCP tool read_document.